Position
Entropy Technologies, LP in Rhythm Pharmaceuticals, Inc.
Back to the book · All holders of RYTM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$50K$107.04 → $86.97
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.49K | $266.7K | — | — | — | 0.0% |
| Q1 2026 | 10.3K | $897.4K | $86.97 | −$50K | $680.6K | 0.0% |